Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Vaccine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2003.08.029PMID 14741162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1

  2003cited by this paper
• Efficient Transduction of Human Monocyte-Derived Dendritic Cells by Chimpanzee-Derived Adenoviral Vector

  2003cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

  2002cited by this paper
• Vaccines: New hope for an aids vaccine

  2002cited by this paper
• Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

  2002cited by this paper
• Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response

  2002cited by this paper
• Clinical trials of HIV vaccines.

  2002cited by this paper
• Oral recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity.

  2002cited by this paper
• Prospects for vaccine protection against HIV-1 infection and AIDS.

  2002cited by this paper
• Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene.

  2001cited by this paper
• Replication-Defective Vector Based on a Chimpanzee Adenovirus

  2001cited by this paper
• Vaccines for the prevention of HIV-1 disease.

  2001cited by this paper
• The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle.

  2000cited by this paper
• Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.

  2000cited by this paper
• The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1.

  1999cited by this paper
• Recombinant adenovirus is an efficient and non‐perturbing genetic vector for human dendritic cells

  1999cited by this paper
• Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation

  1997cited by this paper
• Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

  1997cited by this paper
• Sequential nucleic acid and recombinant adenovirus vaccination induces host‐protective immune responses against Taenia ovis infection in sheep

  1997cited by this paper
• A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

  1996cited by this paper
• Neutralization of HIV-1 by antibody.

  1996cited by this paper
• HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice.

  1996cited by this paper
• Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein

  1989cited by this paper
• Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants.

  1971cited by this paper

• Recombinant Adenovirus Vectors as Mucosal Vaccines

  2020cites this paper
• Adenovirus-mediated Gene Therapy for Allergy.

  2019cites this paper
• Simian adenoviruses as vaccine vectors

  2016cites this paper
• Enhancement of Nasal HIV Vaccination with Adenoviral Vector-Based Nanocomplexes Using Mucoadhesive and DC-Targeting Adjuvants

  2014cites this paper
• Adenoviral vectors coated with cationic PEG derivatives for intravaginal vaccination against HIV-1.

  2014cites this paper
• Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant

  2013cites this paper
• Seroprevalence of neutralizing antibodies to human adenoviruses type‐5 and type‐26 and chimpanzee adenovirus type‐68 in healthy Chinese adults

  2013cites this paper
• Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

  2011cites this paper
• Molecular characterization of adenoviruses in fecal samples of captively bred rhesus macaques in China.

  2011cites this paper
• Delivery of antigens by viral vectors for vaccination.

  2011cites this paper
• Simian recombinant adenovirus delivered by the mucosal route modulates gammadelta T cells from murine genital tract.

  2010cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010cites this paper
• The development of recombinant Adenoviral vaccines to target pneumovirus infection

  2010cites this paper
• An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

  2010cites this paper
• Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys.

  2010cites this paper
• Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In Vivo

  2009cites this paper
• Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity

  2009cites this paper
• Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A

  2008cites this paper
• GENERATION AND CHARACTERIZATION OF THE CELLULAR IMMUNE RESPONSE TO A CLOSTRIDIUM PERFRINGENS ANTI-SIV MUCOSAL VACCINE

  2008cites this paper
• Expression and Purification of a Recombinant Adenovirus Fiber Knob in a Baculovirus System

  2008cites this paper
• Gene Transfer Studies Using Mouse Models

  2007cites this paper
• A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

  2007cites this paper
• In utero oral DNA immunization : induction of specific immunity in the second trimester ovine fetus

  2007cites this paper
• Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

  2007cites this paper
• Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.

  2007cites this paper
• Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.

  2007cites this paper
• Oral administration of the adenovirus vector induces systemic immunity rather than intestinal mucosal immunity.

  2006cites this paper
• A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.

  2006cites this paper
• Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

  2006cites this paper
• Genetic medicine strategies to protect against bioterrorism.

  2006cites this paper
• HIV vaccines: can mucosal CD4 T cells be protected?

  2006cites this paper
• Recombinant viruses as vaccines against viral diseases.

  2005cites this paper
• Adenovirus Vectors Signaling during Vaccination with Cell Induction , Is Dependent on Type I IFN T + Dendritic Cell Maturation , but Not CD 8

  2005cites this paper
• Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity

  2005cites this paper
• Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors1

  2005cites this paper
• Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

  2005cites this paper
• Adenovirus-Based Genetic Vaccines for Biodefense

  2005cites this paper
• Adenoviral Vectors for Mucosal Vaccination Against Infectious Diseases

  2005cites this paper
• Adenoviral gene delivery for HIV-1 vaccination.

  2005cites this paper
• Construction of adenoviral vectors expressing F and G glycoproteins of human respiratory syncytial virus (HRSV)

  2004cites this paper
• Adenoviruses as vaccine vectors

  2004cites this paper
• Efficient Transduction of Human Monocyte-Derived Dendritic Cells by Chimpanzee-Derived Adenoviral Vector

  2003cites this paper
• Pathogenesis and Immune Response

  2002cites this paper